| name | Autologous Fat Transfer |
| Classification | Surgical Procedure/Aesthetic Procedure |
| Pharmacokinetics | Not applicable. Autologous fat transfer does not involve a drug or substance with a pharmacokinetic profile. The transferred fat cells integrate into the recipient tissue over time, and their fate and metabolism are influenced by local factors. |
| Suggested Dosage | Not applicable. The amount of fat transferred is determined by the specific clinical indication and the patient's needs. It's not a fixed dosage. |
| Indications | | 1 | Facial rejuvenation (e.g., reducing wrinkles, enhancing volume) | | 2 | Breast augmentation | | 3 | Buttock augmentation | | 4 | Hand rejuvenation | | 5 | Treating bony defects | | 6 | Repairing tissue damage from burns or trauma | | 7 | Improving skin texture |
|
| Safety in pregnancy | Limited data available. Consult with a physician experienced in autologous fat grafting during pregnancy, as it's a relatively new application in this context. Individual risk assessment is critical, and the potential benefits and risks should be weighed carefully. |
| Safety in breast feeding | Not recommended during breastfeeding. The safety and long-term effects on the infant are unknown. Breastfeeding should be ceased or delayed pending further evaluation in consultation with the treating physician. |
| Side effects | | 1 | Infection | | 2 | Bleeding | | 3 | Swelling | | 4 | Pain | | 5 | Bruising | | 6 | Uneven or asymmetrical results (requiring further surgery) | | 7 | Necrosis (death) of transferred fat cells | | 8 | Seroma formation (fluid collection) | | 9 | Changes in sensation (temporary or permanent) | | 10 | Scarring | | 11 | Delayed healing | | 12 | Changes in skin pigmentation (temporary or permanent) |
|
| Alternatives | | 1 | Fillers (e.g., hyaluronic acid, calcium hydroxylapatite) | | 2 | Other surgical procedures (e.g., liposuction with transfer to another area) | | 3 | Dermal fillers | | 4 | Fat grafting from different sources (e.g., cadaveric fat) |
|
| Contraindications | | 1 | Uncontrolled bleeding disorders | | 2 | Active infections at the treatment site | | 3 | Patient with a history of poor wound healing | | 4 | Severe underlying medical conditions | | 5 | Allergy to the anesthesia or local injection | | 6 | History of excessive scar formation | | 7 | Inability to comply with post-procedure care instructions |
|
| Interactions | No direct drug interactions. Any medications the patient is taking should be discussed with the physician prior to the procedure. |
| Warnings and Precautions | | 1 | Careful patient selection is essential. | | 2 | Procedure should be performed by experienced surgeon or physician. | | 3 | Detailed discussion of desired outcome, realistic expectations, and potential complications is mandatory. | | 4 | Appropriate post-procedure care is crucial to reduce complications. | | 5 | Long-term results are not guaranteed and may require further treatment in some cases. | | 6 | Proper post-operative care and pain management should be discussed. |
|
| Additional Information | | 1 | The effectiveness and longevity of results are variable and depend on many factors, including the patient's age, overall health, and the skill of the surgeon. | | 2 | The process involves harvesting fat from one area of the body and injecting it into another. | | 3 | Multiple sessions may be required to achieve the desired outcome. | | 4 | This is not a quick-fix solution and requires a commitment to follow-up care. |
|
| Patient Details | |
